A study in humans identified the miR-29c-5p as part of a competing endogenous RNA network with potential regulatory roles in sepsis, where it was predicted to interact with TGFBR3 [Zhang et al. DOI:10.1186/s12920-023-01460-8]. In traumatic brain injury research, the miR-29c-5p was found to be altered in the cerebrospinal fluid and saliva of pediatric patients, indicating its potential as a diagnostic biomarker [Li et al. DOI:10.1016/j.neuint.2023.105643].